Article Text

Download PDFPDF

Prognosis of Guillain-Barré syndrome in the African: the Nigerian experience
  1. Benjamin O. Osuntokun,
  2. Kofo Agbebi
  1. Neurology Unit, Department of Medicine, University College Hospital, Ibadan, Nigeria


    The clinical features of the Guillain-Barré syndrome in 34 Nigerian patients are reported. The patients were treated with oral prednisolone 20 mg three times daily for a minimum of six weeks. Twenty-seven patients recovered completely and five others showed considerable improvement, although three of them appeared to be `steroid dependent'. Two patients died. The good prognosis and the response to treatment with prednisolone in this series is in keeping with an allergic demyelinating neuropathy.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.